Sophia Genetics (SOPH) 2025 Investing Outlook for Investors
In 2025, Sophia Genetics is at a crossroads between expanding its software platform and tightening its financial disc...
Biotech
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
88 articles
Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Immortal Life Henrietta Lacks Settlement Moves Forward
A confidential settlement in Maryland ends a high-profile dispute over HeLa cell patents and profits, signaling a new...
Down Over Past Year: Can Hims & Hers Stock Rebound?
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...
Organogenesis (Orgo) 2025 Earnings Outlook and Insights
As investors digest Organogenesis (Orgo) 2025 earnings, the focus shifts to revenue mix, profitability, and upcoming ...
Novocure (NVCR) 2025 Earnings Outlook and Analysis
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Musk, Altman, China Fight for Brain Implant Market
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
Rhythm Pharma (RYTM) Earnings: Investors' Key Takeaways
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...
RxSight (RXST) 2025 Earnings: What Investors Should Do
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Revolution Medicines (RVMD) Earnings: Investor Guide
Dive into a practical guide on Revolution Medicines earnings. Learn to parse transcripts, spot the signals that matte...